KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BILL Holdings (BILL) Research & Development (2018 - 2025)

BILL Holdings has reported Research & Development over the past 8 years, most recently at $82.8 million for Q4 2025.

  • Quarterly results put Research & Development at $82.8 million for Q4 2025, down 2.33% from a year ago — trailing twelve months through Dec 2025 was $339.7 million (up 4.62% YoY), and the annual figure for FY2025 was $340.1 million, up 0.98%.
  • Research & Development for Q4 2025 was $82.8 million at BILL Holdings, up from $80.3 million in the prior quarter.
  • Over the last five years, Research & Development for BILL hit a ceiling of $90.0 million in Q2 2025 and a floor of $22.3 million in Q1 2021.
  • Median Research & Development over the past 5 years was $79.3 million (2022), compared with a mean of $71.3 million.
  • Biggest five-year swings in Research & Development: surged 167.65% in 2022 and later fell 11.65% in 2024.
  • BILL Holdings' Research & Development stood at $51.4 million in 2021, then skyrocketed by 53.59% to $78.9 million in 2022, then rose by 9.6% to $86.5 million in 2023, then decreased by 1.97% to $84.8 million in 2024, then dropped by 2.33% to $82.8 million in 2025.
  • The last three reported values for Research & Development were $82.8 million (Q4 2025), $80.3 million (Q3 2025), and $90.0 million (Q2 2025) per Business Quant data.